Naše publikace

Kuda, O., Březinová, M., Rombaldová, M., Slavíková, B., Pošta, M., Beier, P., Janovská, P., Veleba, J., Kopecký Jr., J., Kudová, E., Pelikánová, T., Kopecký, J. Docosahexaenoic Acid-Derived Fatty Acid Esters of Hydroxy Fatty Acids (FAHFAs) With Anti-inflammatory Properties. Diabetes. 2016, 65(9), 2580–2590. https://doi.org/10.2337/db16-0385

FGÚ

IKEM

ÚOCHB

Holubová, M., Zemenová, J., Mikulášková, B., Panajotová, V., Stöhr, J., Haluzík, M., Kuneš, J., Železná, B., Maletínská, L. Palmitoylated PrRP analog decreases body weight in DIO rats but not in ZDF rats. Journal of Endocrinology. 2016, 229(2), 85–96. https://doi.org/10.1530/joe-15-0519

FGÚ

ÚOCHB

Jirků, M., Lánský, Z., Bednárová, L., Šulc, M., Monincová, L., Majer, P., Vyklický ml., L., Vondrášek, J., Teisinger, J., Boušová, K. The characterization of a novel S100A1 binding site in the N-terminus of TRPM1. International Journal of Biochemistry and Cell Biology. 2016, 78(Sep 2016), 186–193. https://doi.org/10.1016/j.biocel.2016.07.014

FGÚ

ÚOCHB

Kasal, A., Buděšínský, M., Mareš, P., Krištofíková, Z., Leitao, A. J., Sá e Melo, M. L., Silva, M. M. C. Neurosteroids: Can a 2alpha,3alpha-epoxy ring make up for the 3alpha-hydroxyl group? Steroids. 2016, 105(Jan), 12–18. https://doi.org/10.1016/j.steroids.2015.11.007

FGÚ

ÚOCHB

Kuneš, J., Pražienková, V., Popelová, A., Mikulášková, B., Zemenová, J., Maletínská, L. Prolactin-releasing peptide: a new tool for obesity treatment. Journal of Endocrinology. 2016, 230(2), R51–R58. https://doi.org/10.1530/joe-16-0046

FGÚ

ÚOCHB

Mikulášková, B., Zemenová, J., Pirník, Z., Pražienková, V., Bednárová, L., Železná, B., Maletínská, L., Kuneš, J. Effect of palmitoylated prolactin-releasing peptide on food intake and neural activation after different routes of peripheral administration in rats. Peptides. 2016, 75(Jan), 109–117. https://doi.org/10.1016/j.peptides.2015.11.005

FGÚ

ÚOCHB

Mikulášková, B., Maletínská, L., Zicha, J., Kuneš, J. The role of food intake regulating peptides in cardiovascular regulation. Molecular and Cellular Endocrinology. 2016, 436(Nov 15), 78–92. https://doi.org/10.1016/j.mce.2016.07.021

FGÚ

ÚOCHB

Kirubakaran, P., Pfeiferová, L., Boušová, K., Bednárová, L., Obšilová, V., Vondrášek, J. Artificial proteins as allosteric modulators of PDZ3 and SH3 in two-domain constructs: A computational characterization of novel chimeric proteins. Proteins-Structure, Function and Bioinformatics. 2016, 84(10), 1358–1374. https://doi.org/10.1002/prot.25082

FGÚ

ÚOCHB

Pelantová, H., Bugáňová, M., Holubová, M., Šedivá, B., Zemenová, J., Sýkora, D., Kaválková, P., Haluzík, M., Železná, B., Maletínská, L., Kuneš, J., Kuzma, M. Urinary metabolomic profiling in mice with diet-induced obesity and type 2 diabetes mellitus after treatment with metformin, vildagliptin and their combination. Molecular and Cellular Endocrinology. 2016, 431(C), 88–100. https://doi.org/10.1016/j.mce.2016.05.003

FGÚ

ÚOCHB

Slavíková, B., Chodounská, H., Nekardová, M., Vyklický, V., Ladislav, M., Hubálková, P., Krausová, B., Vyklický ml., L., Kudová, E. Neurosteroid-like Inhibitors of N-Methyl-D-aspartate Receptor: Substituted 2-Sulfates and 2-Hemisuccinates of Perhydrophenanthrene. Journal of Medicinal Chemistry. 2016, 59(10), 4724–4739. https://doi.org/10.1021/acs.jmedchem.6b00079

FGÚ

ÚOCHB

Vyklický, V., Smejkalová, T., Krausová, B., Balík, A., Kořínek, M., Borovská, J., Horák, M., Chvojková, M., Kletečková, L., Valeš, K., Černý, J., Nekardová, M., Chodounská, H., Kudová, E., Vyklický ml., L. Preferential Inhibition of Tonically over Phasically Activated NMDA Receptors by Pregnane Derivatives. Journal of Neuroscience. 2016, 36(7), 2161–2175. https://doi.org/10.1523/JNEUROSCI.3181-15.2016

FGÚ

ÚOCHB

Jíchová, Š., Kopkan, L., Husková, Z., Doleželová, Š., Neckář, J., Kujal, P., Vernerová, Z., Kramer, H. J., Sadowski, J., Kompanowska-Jezierska, E., Reddy, N. R., Falck, J. R., Imig, J. D., Červenka, L. Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats. Journal of Hypertension. 2016, 34(10), 2008–2025. https://doi.org/10.1097%2FHJH.0000000000001029

FGÚ

IKEM

Kočková, R., Kačer, P., Pirk, J., Malý, J., Sukupová, L., Sikula, V., Kotrc, M., Barciaková, L., Honsová, E., Malý, M., Kautzner, J., Sedmera, D., Penicka, M. Native T1 Relaxation Time and Extracellular Volume Fraction as Accurate Markers of Diffuse Myocardial Fibrosis in Heart Valve Disease - Comparison With Targeted Left Ventricular Myocardial Biopsy. Circulation Journal. 2016, 80(5), 1202–1209. https://doi.org/10.1253/circj.cj-15-1309

FGÚ

IKEM

Malínská, H., Oliyarnyk, O., Škop, V., Šilhavý, J., Landa, V., Zídek, V., Mlejnek, P., Šimáková, M., Strnad, H., Kazdová, L., Pravenec, M. Effects of Metformin on Tissue Oxidative and Dicarbonyl Stress in Transgenic Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein. PLoS ONE. 2016, 11(3), e0150924. https://doi.org/10.1371%2Fjournal.pone.0150924

FGÚ

IKEM

Pravenec, M., Kožich, V., Krijt, J., Sokolová, J., Zídek, V., Landa, V., Mlejnek, P., Šilhavý, J., Šimáková, M., Škop, V., Trnovská, J., Kazdová, L., Kajiya, T., Wang, J. M., Kurtz, T. W. Genetic Variation in Renal Expression of Folate Receptor 1 (Folr1) Gene Predisposes Spontaneously Hypertensive Rats to Metabolic Syndrome. Hypertension. 2016, 67(2), 335–341. https://doi.org/10.1161/hypertensionaha.115.06158

FGÚ

IKEM

Pravenec, M., Mlejnek, P., Zídek, V., Landa, V., Šimáková, M., Šilhavý, J., Strnad, H., Eigner, S., Eigner-Henke, K., Škop, V., Malínská, H., Trnovská, J., Kazdová, L., Drahota, Z., Mráček, T., Houštěk, J. Autocrine effects of transgenic resistin reduce palmitate and glucose oxidation in brown adipose tissue. Physiological Genomics. 2016, 48(6), 420–427. https://doi.org/10.1152/physiolgenomics.00122.2015

FGÚ

IKEM

Rambousek, L., Kletečková, L., Kubesová, A., Jirák, D., Valeš, K., Fritschy, J.M. Rat intra-hippocampal NMDA infusion induces cell-specific damage and changes in expression of NMDA and GABA_A receptor subunits. Neuropharmacology. 2016, 105(Jun), 594–606. https://doi.org/10.1016/j.neuropharm.2016.02.035

FGÚ

IKEM

Sedmera, D., Neckář, J., Beneš Jr., J., Pospíšilová, J., Petrák, J., Sedláček, K., Melenovský, V. Changes in Myocardial Composition and Conduction Properties in Rat Heart Failure Model Induced by Chronic Volume Overload. Frontiers in physiology. 2016, 7(Aug 25), 367. https://doi.org/10.3389/fphys.2016.00367

FGÚ

IKEM

Šedová, L., Pravenec, M., Křenová, D., Kazdová, L., Zídek, V., Krupková, M., Liška, F., Křen, V., Šeda, O. Isolation of a Genomic Region Affecting Most Components of Metabolic Syndrome in a Chromosome-16 Congenic Rat Model. PLoS ONE. 2016, 11(3), e0152708. https://doi.org/10.1371%2Fjournal.pone.0152708

FGÚ

IKEM

Škop, V., Trnovská, J., Oliyarnyk, O., Marková, I., Malínská, H., Kazdová, L., Zídek, V., Landa, V., Mlejnek, P., Šimáková, M., Kůdela, M., Pravenec, M., Šilhavý, J. Hepatotoxic effects of fenofibrate in spontaneously hypertensive rats expressing human C-reactive protein. Physiological Research. 2016, 65(6), 891–899. https://doi.org/10.33549/physiolres.933304

FGÚ

IKEM